Francis P. Tally - Concepedia

Author

Francis P. Tally

Tufts Medical Center

Also Known As

F P Tally, F Tally, F. P. TALLY, F. P. Tally, F. Tally, F.P. Tally, FRANCIS P. TALLY, Francis P Tally, Francis P. Tally

124

Publications

7.9K

Citations

H-Index

Concepts

All Affiliations

Tufts Medical Center Tufts University United States Department of Veterans Affairs Pearl River Hydraulic Research Institute

About

Francis P. Tally is an author at Tufts Medical Center specializing in medicine, antimicrobial resistance, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	64	4K
2	Health Sciences	27	38	2.4K
3	Natural Sciences	5	5	361
4	Engineering	3	3	223
5	Public Health	1	1	12

Francis P. Tally

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i> Vance G. Fowler, Helen W. Boucher, G. Ralph Corey, New England Journal of Medicine	2006	1.5K
Aerobic and Anaerobic Bacteria in Diabetic Foot Ulcers Thomas Louie, John G. Bartlett, Francis P. Tally, Annals of Internal Medicine Pathogenic MicrobiologyOptimal Microbiologic TechniquesAerobic BacteriaAnaerobic CulturingMicrobial Ecology	1976	230
Daptomycin: a novel agent for Gram-positive infections Francis P. Tally, Michael L. Zeckel, Margaret Wasilewski, Expert Opinion on Investigational Drugs Novel AntibioticsAntimicrobial ChemotherapyDrug ResistanceNovel AgentSmooth Muscle	1999	205
Once-Daily Dosing in Dogs Optimizes Daptomycin Safety Frederick B. Oleson, Carol W. Berman, Jeannie B. Kirkpatrick, Antimicrobial Agents and Chemotherapy	2000	195
Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636 B A Rasmussen, Y Gluzman, Francis P. Tally Antimicrobial Agents and Chemotherapy Class BMicrobial PathogensBacteriologyMolecular BiologyEscherichia Coli	1990	170
Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis G J Cuchural, M H Malamy, Francis P. Tally Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyAntibiotic ResistanceDrug PermeationExcellent Antimicrobial ActivityDrug Resistance	1986	162
Oxygen tolerance of fresh clinical anaerobic bacteria Francis P. Tally, Phyllis Stewart, Vera L. Sutter, Journal of Clinical Microbiology EngineeringOxygen SensitivityMedicineExtremophileMicrobial Physiology	1975	155
Superoxide dismutase in anaerobic bacteria of clinical significance Francis P. Tally, Barry R. Goldin, N V Jacobus, Infection and Immunity Enzyme LevelBiochemistryBacteriologyMicrobial EcologyOxygen Tolerance	1977	147
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation G J Cuchural, Francis P. Tally, N V Jacobus, Antimicrobial Agents and Chemotherapy Antibiotic ResistanceUnited StatesDrug ResistanceMedical MicrobiologyHealthcare-associated Infection	1988	144
Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins Francis P. Tally, N V Jacobus, John G. Bartlett, Antimicrobial Agents and Chemotherapy	1975	133

Page 1